Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial

Autor: Olschewski, H, Delcroix, M, Andrade-Lima, M, de Amorim Corrêac, R, Figueiredo Campos, F, Ota Arakaki, J, Meyer, G, De Souza, R, Langleben, D, Al-Hiti, H, Jansa, P, Mellemkjær, S, Bauer, F, Montani, D, Simonneau, G, Drömann, D, Ghofrani, H-A, Grünig, E, Halank, M, Held, M, Hoeper, MM, Klose, H, Kneidinger, N, Leuchte, H, Opitz, C, Rosenkranz, S, Wilkens, H, Wirtz, H, Karvounis, H, Pitsiou, G, Orfanos, S, D'Alto, M, Ghio, S, Vizza, CD, Vitulo, P, Nakayama, T, Maki, H, Tatebe, S, de los Rios Ibarra, M, Pulido, T, Van Dijk, A, Vonk-Noordegraaf, A, Roleder, T, Castro, G, Loureiro, MJ, Robalo-Martins, S, Barberá, JA, Lázaro, M, Perez-Penate, GM, Román, A, Cheng, C-C, Hsu, C-H, Hsu, H-H, Atahan, E, Mogulkoc Bishop, N, Okumus, NG, Onen, Z, Chang, H-J, Chang, S-A, Lee, J-S, Kim, H-K, Coghlan, JG, Corris, PA, Church, AC, Condliffe, R, Gibbs, JSR, Peacock, AJ, Wort, S, Allen, R, Allen, S, Awdish, R, Benza, RL, DeSouza, S, Feldman, J, Johri, S, Klinger, JR, Layish, D, McConnell, J, McLaughlin, VV, Migliore, C, Rahaghi, F, Rischard, F, Robbins, I, Satterwhite, L, Shah, T, Sulica, R, White, RJ, Hoeper, Marius M ^*, Al-Hiti, Hikmet, Benza, Raymond L, Chang, Sung-A, Corris, Paul A, Gibbs, J Simon R, Grünig, Ekkehard, Jansa, Pavel, Klinger, James R, Langleben, David, McLaughlin, Vallerie V, Meyer, Gisela M B, Ota-Arakaki, Jaquelina, Peacock, Andrew J, Pulido, Tomás, Rosenkranz, Stephan, Vizza, Carmine Dario, Vonk-Noordegraaf, Anton, White, R James, Chang, Mikyung, Kleinjung, Frank, Meier, Christian, Paraschin, Karen, Ghofrani, Hossein Ardeschir ^*, Simonneau, Gérald ^*

Publikováno v: In The Lancet Respiratory Medicine June 2021 9(6):573-584

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia

Autor: Kolditz, M., Halank, M., Schulte-Hubbert, B., Bergmann, S., Albrecht, S., Höffken, G.

Publikováno v: In Respiratory Medicine September 2012 106(9):1320-1328

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Quality of life 3 and 12 months following acute pulmonary embolism analysis from a prospective multicenter cohort study

Autor: Valerio, L., Barco, S., Jankowski, M., Rosenkranz, S., Lankeit, M., Held, M., Gerhardt, F., Bruch, L., Ewert, R., Faehling, M., Freise, J., Ghofrani, H.A., Grunig, E., Halank, M., Hoeper, M.M., Klok, F.A., Leuchte, H.H., Mayer, E., Meyer, F.J., Neurohr, C., Opitz, C., Schmidt, K.H., Seyfarth, H.J., Trudzinski, F., Wachter, R., Wilkens, H., Wild, P.S., Konstantinides, S.V.

Publikováno v: Chest, 159(6), 2428-2438. ELSEVIER

Few data are available on the long-term course and predictors of quality of life (QoL) following acute pulmonary embolism (PE).What are the kinetics and determinants of disease-specific and generic health-related QoL 3 and 12 months following an acut

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::aee9ae147a366b4c73c92a969ef35cc9
https://hdl.handle.net/1887/3230180